Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (29)

2024

  1. GEDEFO-SEFH management of antineoplastic extravasations survey results

    Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77

2023

  1. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study

    Annals of Hematology, Vol. 102, Núm. 8, pp. 2069-2075

2022

  1. Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO)

    Journal of Oncology Pharmacy Practice, Vol. 28, Núm. 5, pp. 1170-1181

2021

  1. Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 198-203

  2. Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 184-192

2020

  1. Predictive biomarkers of response to immune checkpoint inhibitors

    Farmacia Hospitalaria, Vol. 44, Núm. 4, pp. 141-148

2019

  1. Variability of carboplatin dose calculation methods in Spain

    Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 7, pp. 1551-1557

2018

  1. Observational study of drug-drug interactions in oncological inpatients

    Farmacia Hospitalaria, Vol. 42, Núm. 1, pp. 10-15

2017

  1. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients

    Farmacia Hospitalaria, Vol. 41, Núm. 5, pp. 611-617

2016

  1. Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use

    Journal of Oncology Pharmacy Practice, Vol. 22, Núm. 5, pp. 659-665

2015

  1. Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 6, pp. 1021-1027

2014

  1. Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 6, pp. 1160-1169

2013

  1. Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 3, pp. 339-343

  2. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 6, pp. 1105-1112

  3. Severe systemic inflammatory response syndrome associated to clofarabine

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 46-48

2012

  1. Toxicidad asociada a la cirugía citorreductora y quimioterapia intraperitoneal hipertérmica en el tratamiento de la carcinomatosis peritoneal

    Farmacia Hospitalaria, Vol. 36, Núm. 2, pp. 60-67

2011

  1. Experiencia de uso de partículas DC Bead ® cargadas con doxorrubicina en quimioembolización hepática

    Farmacia Hospitalaria, Vol. 35, Núm. 4, pp. 172-179

2009

  1. Therapeutic use and profile of toxicity of the FOLFOX4 regimen

    Farmacia Hospitalaria

2007

  1. Errores de prescripción en quimioterapia

    Farmacia Hospitalaria, Vol. 31, Núm. 3, pp. 161-164

2003

  1. Implicación de alopurinol y rofecoxib en agranulocitosis y necrosis tubular aguda

    Farmacia Hospitalaria, Vol. 27, Núm. 5, pp. 317-322